The Cooper Companies, Inc. (NASDAQ:COO) Shares Bought by Cerity Partners LLC

Cerity Partners LLC lifted its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 6.6% during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 17,113 shares of the medical device company’s stock after acquiring an additional 1,054 shares during the period. Cerity Partners LLC’s holdings in Cooper Companies were worth $1,443,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also recently modified their holdings of the company. Price T Rowe Associates Inc. MD lifted its holdings in Cooper Companies by 517.0% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 3,529,477 shares of the medical device company’s stock worth $324,466,000 after buying an additional 2,957,421 shares in the last quarter. Norges Bank purchased a new position in Cooper Companies in the fourth quarter valued at $217,906,000. FMR LLC grew its stake in Cooper Companies by 97.6% during the 4th quarter. FMR LLC now owns 2,218,112 shares of the medical device company’s stock worth $203,911,000 after purchasing an additional 1,095,805 shares in the last quarter. SG Americas Securities LLC increased its holdings in Cooper Companies by 8,337.0% during the 1st quarter. SG Americas Securities LLC now owns 369,542 shares of the medical device company’s stock worth $31,171,000 after purchasing an additional 365,162 shares during the period. Finally, Northern Trust Corp raised its position in Cooper Companies by 15.4% in the 4th quarter. Northern Trust Corp now owns 2,018,898 shares of the medical device company’s stock valued at $185,597,000 after purchasing an additional 268,972 shares in the last quarter. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Cooper Companies Trading Down 1.8%

NASDAQ COO opened at $71.32 on Tuesday. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.23 and a current ratio of 2.10. The Cooper Companies, Inc. has a one year low of $65.00 and a one year high of $112.38. The company has a 50-day simple moving average of $74.03 and a 200-day simple moving average of $81.92. The firm has a market capitalization of $14.26 billion, a PE ratio of 34.62, a price-to-earnings-growth ratio of 1.77 and a beta of 0.99.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings results on Thursday, May 29th. The medical device company reported $0.96 EPS for the quarter, beating the consensus estimate of $0.93 by $0.03. The company had revenue of $1 billion for the quarter, compared to analyst estimates of $995.12 million. Cooper Companies had a net margin of 10.39% and a return on equity of 9.60%. Cooper Companies’s revenue was up 6.3% compared to the same quarter last year. During the same quarter last year, the business earned $0.85 earnings per share. On average, equities analysts forecast that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several equities analysts have issued reports on the company. Wells Fargo & Company dropped their price objective on Cooper Companies from $118.00 to $93.00 and set an “overweight” rating on the stock in a report on Friday, May 30th. Needham & Company LLC raised Cooper Companies from a “hold” rating to a “buy” rating and set a $94.00 price objective for the company in a report on Tuesday, June 17th. Loop Capital set a $100.00 target price on shares of Cooper Companies in a research report on Tuesday, June 17th. Mizuho reduced their price objective on Cooper Companies from $105.00 to $90.00 and set an “outperform” rating for the company in a research note on Wednesday, July 16th. Finally, Piper Sandler reiterated an “overweight” rating and issued a $105.00 target price (down from $115.00) on shares of Cooper Companies in a research note on Friday, May 30th. Four research analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. According to MarketBeat.com, Cooper Companies presently has an average rating of “Moderate Buy” and an average target price of $97.20.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.